Babraham Bioscience Technologies

News & Events

Press Releases

25th July 2008
Pronostics set for European expansion with digital multiplexing solution

24th June 2008
Biosciences scoop over £7M from Government commercialisation fund
Media Coverage of Press Release Jun 2008 – Biosciences scoop over £7m from Government commercialisation fund
•  ‘Funds to commercialise public sector research', UK trade and investment services, http://www.ukinvest.gov.uk/OurWorld/4031921/en-GB.html
•  ‘New funding to turn scientific discoveries into successful businesses', Public Technology.net, http://www.publictechnology.net/modules.php?op=modload&name=News&file=article&sid=16306
•  £4 Million farm research awards are hailed, The Aberdeen Press and Journal, http://www.pressandjournal.co.uk/Article.aspx/704331?UserKey=0
•  ‘Biosciences scoop over £7m from Government commercialisation fund', MediaNewswire.com, http://media-newswire.com/release_1068094.html
•  ‘Moredun deal culmination of years of work', business.scotsman.com, http://business.scotsman.com/fooddrinkagriculture/Moredun-deal-culmination-of-years.4214100.jp

18th June 2008
MedCell and NovaThera Merge

09 May 2008
Babraham's 5th Biotechnology Investment Forum draws French Biotech Companies

06 May 2008
Isogenica completes acquisition of the principal assets of Karyon CTT

04 April 2008
Biovitrum's unique neuropathic pain compound is very safe and shows positive effect

01 April 2008
NOVAPOD™ - Anglo-China Manufacturing Agreement Signed Following Market Success

13 March 2008
NovaThera signs Licensing Agreement for 3D Stem Differentiation and Production

12 March 2008
Antibody Engineering Company F-Star Opens Second Research Site in Cambridge, UK

12 March 2008
Pronostics signs distribution agreement with MEDIPAN GmbH to sell its lead products in Europe's largest diagnostics market

19 February 2008
Population Genetics Technologies Raises £3.8M in Series A Funding; Appoints Mel N. Kronick Chief Executive Officer

15 February 2008
Stem Cell Sciences Implements Strategic Reorganisation

14 February 2008
Senexis and O2H (Oxygen Healthcare) announce medicinal chemistry collaboration

06 February 2008
Probe Scientific takes a major step forward with development and distribution plans

05 February 2008
SENEXIS JOINS INTERNATIONAL RESEARCH CONSORTIUM: European Union grants £3 million to the consortium for research into the investigation of memory loss in Alzheimer's disease

30 January 2008
Stem Cell Sciences Enters Agreement with Myelin Repair Foundation to Develop Sustainable Cell Sources for CNS Drug Discovery

17 January 2008
Senexis Raises £3.7M from the Wellcome Trust & BTG to Further Develop its Small Molecule Alzheimer's Compounds

17 December 2007
Aitua Ltd Portfolio Company Establishes Worldwide Distributor Network

13 December 2007
Antitope Limited UK announces EpiScreen™ collaboration with UCB

29 November 2007
Traditional Chinese Medicine Company announced as the 50th Company to join the Babraham Bioincubator at the official opening of ‘Meditrina'

21 November 2007
Biotechnology Investment Forum bridges the bioclusters in Babraham and Boston, USA

20 November 2007
Babraham and JETRO Cooperate to bring Japanese Bioventures to the Cambridge Region

15 November 2007
NovaPod™ -A New Device for Stem Cell Applications

15 October 2007
NovaThera Research Expansion

08 October 2007
NovaTex™ a new nanoglass textile material for medical applications

25 September 2007
Antitope Announces Research Agreement with Fraunhofer Institute for Cell Therapy and Immunology

21 August 2007
SCS Consolidates Business Through Technology Buy-Back

26 July 2007
New Bioincubation Facilities on the Babraham Research Campus set to open in September 2007

02 July 2007
NovaThera Limited announces appointment of Dr John Beadle as CEO

09 May 2007
NovaThera and Gamida Cell Announce a Collaboration Agreement

 

 

 

 

 

 

 

 

 

Privacy Policy | Contact Us | ©2007 Babraham Research Campus, Babraham, Cambridge CB22 3AT    T: +44 (0)1223 496269